Added to YB: 2025-09-18
Pitch date: 2025-09-16
VETO.PA [neutral]
Vetoquinol SA
-10.38%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
Market Cap
EUR 833.3M
Pitch Price
EUR 79.22
Price Target
N/A
Dividend
1.30%
EV/EBITDA
5.73
P/E
14.53
EV/Sales
1.19
Sector
Pharmaceuticals
Category
N/A
Vetoquinol (VETO France): Margins surprise positively despite soft top-line
VETO.PA (quick overview): H1 revenue flat but op margin expanded 160bps to 16%+ via pricing, favorable mix & opex control. Strategic brands (2/3 of sales) grew 4%+ driving profitability despite soft Europe/Americas demand. Strong €160M net cash balance supports M&A optionality. Consensus expects mid-single digit revenue growth.
Read full article (2 min)